Delays to Neoadjuvant Chemotherapy Have Risks in Bladder Cancer

Several factors, including race, insurance, and type of facility, were associated with delays in neoadjuvant chemotherapy treatment for bladder cancer patients.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news